Gafko Gida Dis Tic.

5 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• PESTICIDE4 refused lines

  Pesticide chemical residue

  The product appeared to contain a pesticide chemical residue that makes it adulterated under section 402(a)(2)(B) of the FD&C Act, for example a residue above the U.S. tolerance or one with no U.S. tolerance for that food.

• INCONSPICU1 refused line

  Required information not conspicuous

  Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• TRANSFAT1 refused line

  TRANSFAT

Questions about Gafko Gida Dis Tic.

Is Gafko Gida Dis Tic. on an FDA import alert?

Yes. As of October 25, 2026, Gafko Gida Dis Tic. is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for tahini; FDA published the listing on May 23, 2018.

Has FDA refused shipments from Gafko Gida Dis Tic.?

Yes. FDA refused 4 shipment lines from Gafko Gida Dis Tic. between June 12, 2018 and November 19, 2018. The most recent, on November 19, 2018, was sesame seed paste (e.g., tahina), edible seed prod., charged as PESTICIDE (pesticide chemical residue).

Why did FDA refuse Gafko Gida Dis Tic.'s shipments?

The most frequent charges are PESTICIDE (pesticide chemical residue, 4 lines) and INCONSPICU (required information not conspicuous, 1 line).

What is Gafko Gida Dis Tic.'s FEI number?

Gafko Gida Dis Tic.'s FDA Establishment Identifier (FEI) is 3011306257.

Can shipments from Gafko Gida Dis Tic. still enter the U.S.?

Shipments of tahini from Gafko Gida Dis Tic. can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).